Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases
about
Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapyPrediction models of hepatocellular carcinoma development in chronic hepatitis B patientsAssociation of 5-methylcytosine and 5-hydroxymethylcytosine with mitochondrial DNA content and clinical and biochemical parameters in hepatocellular carcinomaRisk prediction models for hepatocellular carcinoma in different populations.Cohort Profile: The Taiwan MJ Cohort: half a million Chinese with repeated health surveillance data.Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk.A potentially functional variant of ARID1B interacts with physical activity in association with risk of hepatocellular carcinoma.Association between metabolic factors and chronic hepatitis B virus infection.Chemopreventive strategies in hepatocellular carcinomaThe Relationship of Diabetes and Smoking Status to Hepatocellular Carcinoma MortalityThe aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.Prospective and longitudinal evaluations of telomere length of circulating DNA as a risk predictor of hepatocellular carcinoma in HBV patients.Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population.Low Frequency of Peripheral Lymphocyte in Chronic Hepatitis B Patients Predicts Poor Progression to Hepatocellular Carcinoma.Development and validation of a risk prediction model for end-stage renal disease in patients with type 2 diabetes.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C.The 6th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2015): Evidence and Consensus on HCC Management.Interaction and joint effect of ALT and chronic liver disease on liver cancer in type 2 diabetes patients.Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population.The status of transarterial chemoembolization treatment in the era of precision oncology.Anti-tumoral effects of exercise on hepatocellular carcinoma growth.ABO blood types and cancer risk--a cohort study of 339,432 subjects in Taiwan.Mass screening for liver cancer: results from a demonstration screening project in Zhongshan City, China
P2860
Q27022899-B7FA013F-C40A-4BA7-A48E-AE7CF3027C1BQ28066959-A56164A7-67A2-48A6-889A-FC4A4C23F437Q28534409-76841A59-1590-41DC-AB0E-857ADD69F7C2Q30383460-9F2CC54E-5833-4906-B693-94D305F2DD4AQ31162374-F695AD1E-66D4-4B5E-A53A-8FB0037E880FQ33585044-6F56E360-96A8-4B7F-AF56-D0323DD0551DQ33761625-795C5F46-0A7D-4870-B082-862CFA33F5C5Q33780113-A4A696BB-FA28-491E-BEBD-968968B948D7Q35101365-A2DBD957-0B10-4465-8459-D4697AE38B52Q36580952-DCAD3688-509A-4B53-BDA1-C4DEE7C7C477Q37656478-D109FE99-0650-443D-B4E6-E3B769A45A45Q40277999-1AE68C46-387D-44AF-B389-E19B3362CB8BQ40684396-029B87C1-F149-4607-B2E2-E410E77BA742Q41561869-8A0A054B-B528-420A-AAD4-9A9C6E69E88FQ41580258-9776277C-F6BA-4355-AFAE-C7F7C32DA7EDQ41921861-79E9FA59-6D47-4585-8500-4331A97251ADQ41927269-8AB0C828-4EFC-4482-BED3-276ECD8E1B6FQ46027563-6B7DBD50-17B0-49AA-9609-A373573C4B70Q47097925-6E835803-49D6-4566-B175-31A62BD7533EQ47692611-975F8385-DC2F-4B1D-9AAA-66309934F906Q49491370-1ABE7F47-26D5-4726-B0F4-BC876AA23E3FQ54979103-F4E57389-3DAD-4851-B763-1D545A440216Q55126913-5DE6F9C5-1F91-4CD2-8005-BA540901B4B5Q58708277-566F6D7F-9397-4657-B533-5E499A3AE50D
P2860
Hepatocellular carcinoma risk prediction model for the general population: the predictive power of transaminases
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Hepatocellular carcinoma risk ...... dictive power of transaminases
@en
type
label
Hepatocellular carcinoma risk ...... dictive power of transaminases
@en
prefLabel
Hepatocellular carcinoma risk ...... dictive power of transaminases
@en
P2093
P2860
P356
P1476
Hepatocellular carcinoma risk ...... dictive power of transaminases
@en
P2093
Carol Etzel
Chi-Pang Wen
Chwen Keng Tsao
Ernest Hawk
Lopa Mishra
Maosheng Huang
Min Kuang Tsai
Yi Chen Yang
P2860
P304
P356
10.1093/JNCI/DJS372
P407
P50
P577
2012-10-01T00:00:00Z